MedTrace Logo

Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass

NCT01477788 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-06-18

No results posted yet for this study

Summary

The objective of the study is to create a test that will discriminate between malignant and benign ovarian mass that was diagnosed by ultrasound. The investigators will examine about 800 women and at the end of the study the investigators will combine data from the woman's history, the sonographic characters of the mass and serum biological markers along with the woman's outcome (which means - whether the mass was malignant, benign, or disappeared or remained constant with no intervention).

Conditions

  • Ovarian Neoplasm

Sponsors & Collaborators

  • Women and Infants Hospital of Rhode Island

    collaborator OTHER

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • yfat kadan, MD · Department of Ob/Gyn, Haemek medical center, Afula Israel

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477788 on ClinicalTrials.gov